Yes Nader moved the CC back to actually have news for the CC.
I'll say that again. Nader postponed the Conference Call to have news to report. That means the Conference Call is/was going to be fluff. Now don't get me wrong, getting a letter of intent is all fine and good. But there is one piece of the puzzle missing. Approval.
Everything hinges on approval. There are several companies with agreements to distribute in Brazil pending approval. So it's a horse race. First one there is the first one to the market share.
Could Brazil go with a study that uses only 16% of it's patients for it's results? They could. Brazil is hurting badly enough that you would think they would. But Brazil has been hurting for some time and it has not rushed through other drugs or bypassed clinical trials.
So we had news like this in the past. Sounded great, next few days shorts came in and knocked the price down because well, no actual news.
An EUA is the only thing that keeps the price up, also the only thing that gets revenue going too.
Good luck.